Examining the U.S. Public Health Response to the Zika Virus, Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, Second Session, March 2, 2016   [open pdf - 6MB]

This is the March 2, 2016 hearing on "Examining the U.S. Public Health Response to the Zika Virus" held before the House of Representatives Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce. From the opening statement of Subcommittee Chairman Tim Murphy: "This morning we'll be examining this other public health crisis affecting the Western Hemisphere, that Zika virus. This virus of mosquito-borne pathogen is currently rampaging through South and Central America, and in total has spread to more than 48 countries and territories. [...] The Administration's response to Zika raises very serious questions. There are no commercially available diagnostic tests for Zika, nor has a vaccine been developed. In the absence of these measures, mosquito control is the nation's critical defense. However, mosquito control in the U.S. is a patchwork of 700 mosquito abatement districts depending on the state, county, and city funding and personnel with varying capabilities. This unorganized hodgepodge could leave the U.S. vulnerable to a rapid outbreak of Zika. The Administration has not explained how its emergency request will address issues with vector control. We want to work with the Administration to solve that problem." Statements, letters, and materials submitted for the record include those of the following: Nicole Lurie, Thomas Frieden, Anthony Fauci, Luciana Borio, Timothy Persons, Peter Hotez, Lawrence O. Gostin, Joseph Conlon, Jeanne Sheffield.

Report Number:
Serial Number 114-124; Serial No. 114-124
Public Domain
Retrieved From:
Government Publishing Office: http://www.gpo.gov/
Media Type:
Help with citations